Molecular properties of apelin: tissue distribution and receptor binding

Yuji Kawamata, Yugo Habata, Shoji Fukusumi, Masaki Hosoya, Ryo Fujii, Shuji Hinuma, Naoki Nishizawa, Chieko Kitada, Haruo Onda, Osamu Nishimura, Masahiko FujinoBiochimica 2001 · DOI

TL;DR

This study investigates the distribution and molecular forms of apelin, a peptide hormone, in rats, revealing its presence across various tissues and identifying distinct molecular variants. Crucially, it demonstrates that these different apelin forms exhibit varying binding affinities and dissociation kinetics with their receptor, APJ, suggesting a nuanced biological signaling mechanism.

What Problem Does This Paper Address?

Apelin is a recently identified peptide hormone that acts as the endogenous ligand for the orphan G protein-coupled receptor (GPCR) APJ. While its existence and basic function (promoting extracellular acidification and inhibiting cAMP production) were known, significant questions remained regarding its physiological roles, particularly concerning its distribution within the body and the nature of its interaction with APJ. Specifically, it was unclear if apelin existed in different molecular forms in various tissues and how these forms might influence receptor binding and downstream signaling. This paper aims to fill this knowledge gap by comprehensively analyzing apelin's tissue distribution, identifying its molecular heterogeneity, and characterizing the binding properties of different apelin variants to APJ.

Methods

The researchers employed a multi-pronged approach:

  • Quantitative Reverse Transcription-Polymerase Chain Reaction (RT-PCR): Used to measure the abundance of apelin mRNA in various rat tissues, providing insight into where apelin is synthesized.
  • Enzyme Immunoassay (EIA): Developed using a specific monoclonal antibody (mAb) to quantify immunoreactive apelin (ir-apelin) in tissue extracts. This method allowed for the measurement of the actual apelin protein levels.
  • Gel Filtration Chromatography: Combined with EIA, this technique was used to separate and identify different molecular weight forms of endogenous apelin present in tissue extracts, revealing molecular heterogeneity.
  • Scatchard Analysis: A standard method for characterizing receptor-ligand interactions, used to determine the affinity (Ka) and density (Bmax) of APJ binding sites in cell membranes.
  • Competitive Binding Assays: Used to assess how effectively different apelin analogues could inhibit the binding of a labeled apelin analogue to APJ, helping to understand the relative binding affinities of various apelin forms.
  • Time-Course Dissociation Assays: Measured how quickly radiolabeled apelin analogues dissociated from APJ when challenged with unlabeled apelin, providing insights into the stability of the ligand-receptor complex.
  • Peptide Synthesis: Various apelin analogues were synthesized to test specific hypotheses about epitope recognition and receptor binding.

Datasets

Not discussed in the paper. The study utilized synthesized peptides and biological samples (rat tissues and cell membranes) for their experiments.

Key Insights and Ideas

  • Ubiquitous but Varied Expression: Apelin mRNA and protein are found in most rat tissues, but their levels vary significantly, with particularly high expression in the lung and mammary gland. This suggests apelin plays diverse roles across the body.
  • Molecular Heterogeneity Matters: Endogenous apelin exists in at least two major molecular forms: a "long form" (similar to apelin-36) and a "short form" (similar to [<Glu65]apelin-13). The relative abundance of these forms differs by tissue, with the mammary gland exhibiting a notable mix.
  • Differential Receptor Interaction: The long form (apelin-36) binds to the APJ receptor with higher affinity and dissociates more slowly than the short form ([<Glu65]apelin-13). This suggests that the structural differences between these apelin variants lead to distinct binding kinetics and potentially different biological outcomes.
  • Epitope Specificity of the Antibody: The developed monoclonal antibody primarily recognizes the C-terminal portion of apelin, specifically the (65-76)-peptide sequence, which is crucial for its reactivity.

Key Results

  • Tissue Distribution: Apelin mRNA was highest in the mammary gland (post-parturition) and lung. Ir-apelin levels mirrored mRNA distribution, with the mammary gland and lung showing the highest concentrations. Plasma levels of ir-apelin were significantly lower than in tissues.
  • Molecular Forms: In the lung, testis, and uterus, the long form of apelin (apelin-36) was the major component. The mammary gland contained both long and short forms.
  • Receptor Binding: Apelin-36 bound to APJ with high affinity (Ka = 6.3 pM). Apelin-36 and apelin-19 were potent inhibitors of labeled apelin-36 binding, while [<Glu65]apelin-13 was a weak inhibitor.
  • Dissociation Kinetics: Unlabeled apelin-36 dissociated the labeled apelin-36 analogue from APJ more effectively than [<Glu65]apelin-13, indicating that the apelin-36-APJ complex is more stable.

Limitations and Future Work

  • Mammary Gland Heterogeneity: The reason for the significant heterogeneity of apelin forms in the mammary gland remains unclear and warrants further investigation.
  • Association Kinetics: While dissociation kinetics differed, the paper notes that more precise analyses are needed to clarify differences in the association kinetics of apelin forms with APJ.
  • Physiological Roles: While the study identifies distribution and binding properties, the precise physiological roles of the different apelin forms and their specific contributions to APJ signaling in various tissues require further elucidation. The authors speculate on apelin's role in neonates via oral intake and its potential involvement in neuromodulation and morphogenesis.
  • HIV Co-receptor Function: The paper touches upon APJ's role as an HIV co-receptor and notes that apelin-36 is more effective than [<Glu65]apelin-13 in inhibiting HIV infection, suggesting that dissociation kinetics might be more relevant than association kinetics in this context. This area could be a fruitful avenue for future research.

Summary updated

BibTeX
@inproceedings{kawamata2001molecular,
  author = {Yuji Kawamata and Yugo Habata and Shoji Fukusumi and Masaki Hosoya and Ryo Fujii and Shuji Hinuma and Naoki Nishizawa and Chieko Kitada and Haruo Onda and Osamu Nishimura and Masahiko Fujino},
  title = {{Molecular properties of apelin: tissue distribution and receptor binding}},
  booktitle = {Biochimica},
  year = {2001},
  doi = {10.1016/s0167-4889(00)00143-9},
}
Figure